Home Stock

Stock Research: Abbott Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Abbott Laboratories

NYQ:ABT US0028241000
94
  • Value
    88
  • Growth
    81
  • Safety
    Safety
    52
  • Combined
    94
  • Sentiment
    59
  • 360° View
    360° View
    94
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad line of healthcare products. It operates in the Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices industries. The company serves people in over 160 countries. In the last fiscal year, the company had a market cap of $228,771 million, profits of $23,306 million, and revenue of $41,950 million with 114000 employees.

more

ANALYSIS: With an Obermatt 360° View of 94 (better than 94% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Abbott Laboratories are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Abbott Laboratories. The consolidated Value Rank has an attractive rank of 88, which means that the share price of Abbott Laboratories is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 88% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 52. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 59. ...read more

more
Strongest Rank Opinions Change
Weakest Rank Dividend Yield
Country USA
Industry Health Care Equipment
Size Medium
Website abbott.com
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Abbott Laboratories stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 59 62 87
Growth
81 55 49 45
Safety
Safety
52 81 42 30
Sentiment
59 90 83 95
360° View
360° View
94 98 86 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
48 69 62 64
Opinions Change
30 49 48 50
Pro Holdings
n/a 96 83 97
Market Pulse
85 97 78 78
Sentiment
59 90 83 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 59 62 87
Growth
81 55 49 45
Safety Safety
52 81 42 30
Combined
94 91 56 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
45 33 35 51
Price vs. Earnings (P/E)
41 35 44 54
Price vs. Book (P/B)
47 35 31 43
Dividend Yield
100 96 98 98
Value
88 59 62 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
60 45 17 7
Profit Growth
98 49 30 70
Capital Growth
45 42 73 36
Stock Returns
37 69 67 81
Growth
81 55 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
53 58 44 41
Refinancing
36 17 9 3
Liquidity
77 95 86 76
Safety Safety
52 81 42 30

Similar Stocks

Discover high‑ranked alternatives to Abbott Laboratories and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Merck (USA)

NYQ:MRK
Country: USA
Industry: Pharmaceuticals
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews